• Citer

Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982).

par van Herpen, C M L;Locati, L D;Buter, J;Thomas, José;Bogaerts, J;Lacombe, Denis;de Mulder, Pieter;Awada, Ahmad ;Licitra, L;Bernier, J;Vermorken, Jan Baptist
Référence European journal of cancer, 44, 17, page (2542-2545)
Publication Publié, 2008-11

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982).
Auteur:	van Herpen, C M L; Locati, L D; Buter, J; Thomas, José; Bogaerts, J; Lacombe, Denis; de Mulder, Pieter; Awada, Ahmad; Licitra, L; Bernier, J; Vermorken, Jan Baptist
Informations sur la publication:	European journal of cancer, 44, 17, page (2542-2545)
Statut de publication:	Publié, 2008-11
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Adenoid cystic carcinoma
	Gemcitabine
	Head and neck cancer
	Salivary gland tumours
MeSH keywords:	Adult
	Aged
	Antimetabolites, Antineoplastic -- administration & dosage
	Antimetabolites, Antineoplastic -- adverse effects
	Carcinoma, Adenoid Cystic -- drug therapy
	Deoxycytidine -- administration & dosage
	Deoxycytidine -- adverse effects
	Deoxycytidine -- analogs & derivatives
	Female
	Head and Neck Neoplasms -- drug therapy
	Humans
	Infusions, Intravenous
	Male
	Middle Aged
	Neoplasm Recurrence, Local -- drug therapy
	Patient Compliance
	Treatment Outcome
Note générale:	Clinical Trial, Phase II
	Journal Article
	Multicenter Study
	Research Support, N.I.H., Extramural
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0959-8049
	info:doi/10.1016/j.ejca.2008.08.014
	info:pii/S0959-8049(08)00663-1
	info:scp/55249089179
	info:pmid/18819792